Loading...
Loading...
Browse all stories on DeepNewz
VisitAbbVie Secures FDA Approval for Injectable Parkinson's Drug After Rejections on October 17
Oct 17, 2024, 08:36 PM
AbbVie has received approval from the FDA for a new injectable drug aimed at alleviating symptoms of Parkinson's disease. This approval comes after previous rejections and represents a significant advancement in treatment options for patients suffering from Parkinson's and related disorders. The drug has shown efficacy in reducing symptoms and improving motor fluctuations in clinical study participants. The approval has been welcomed by advocates and lawmakers, who emphasize the importance of accessible and effective medications for millions of families affected by these conditions.
View original story
Markets
Yes • 50%
No • 50%
Quarterly financial reports from AbbVie or statements from AbbVie indicating sales figures
No • 50%
Yes • 50%
World Health Organization's official publications or announcements
No • 50%
Yes • 50%
Court filings or official legal announcements involving AbbVie's new drug
Less than 10% • 25%
More than 30% • 25%
20% to 30% • 25%
10% to 20% • 25%
Market analysis reports from reputable firms or AbbVie's official statements
Other • 25%
North America • 25%
Europe • 25%
Asia-Pacific • 25%
Sales reports from AbbVie or market analysis reports
Biogen • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Industry reports, market analysis, or sales data